experimental group:BHA chemotherapy

2 trials

Sponsors

The Second Affiliated Hospital of Dalian Medical University

Conditions

Elderly patients with acute myeloid leukemia/high risk myelodysplastic syndromerelapsed / refractory acute myeloid leukemia

Early Phase 1

Clinical study of induction remission therapy for relapsed / refractory acute myeloid leukemia with BHA combined chemotherapy regimen

Active, not recruitingChiCTR2000029841

The Second Affiliated Hospital of Dalian Medical Universityrelapsed / refractory acute myeloid leukemia

Start: 2019-10-01Updated: 2023-08-07

Unknown Phase

Clinical study for BHA combined with chemotherapy in the treatment of elderly patients with acute myeloid leukemia /high risk myelodysplastic syndrome

RecruitingChiCTR2000029772

The Second Affiliated Hospital of Dalian Medical UniversityElderly patients with acute myeloid leukemia/high risk myelodysplastic syndrome

Start: 2020-02-15Updated: 2022-03-07

Related Papers

Effectiveness of chemotherapy using bortezomib combined with homoharringtonine and cytarabine in refractory or relapsed acute myeloid leukemia: a phase II, multicenter, prospective clinical trial

Frontiers in Oncology2023-08-182 citations

P578: EFFECTIVENESS OF REINDUCTION CHEMOTHERAPY USING BORTEZOMIB WITH HOMOHARRINGTONINE AND CYTARABINE IN REFRACTORY OR RELAPSED ACUTE MYELOID LEUKEMIA: A PHASE II, MULTICENTER, PROSPECTIVE CLINICAL TRIAL

HemaSphere2023-08-01